Insiders who reported open-market trades in the last 12 months at the companies James Mulay files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Brian Guan-Chyun Liu - $24.81M in CGON purchases and sales in the last 12 months
Leonard E. Post - $1.05M in CGON purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
James Mulay is a corporate insider of CG Oncology, Inc. (CGON). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James Mulay last file a Form 4?
The most recent primary Form 4 on record is dated 14 July 2026, one of 11 filings going back to 2024.
Has James Mulay been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($6.28M) across all tracked filings.
James Mulay files SEC Form 4 reports at CG Oncology, Inc. (CGON). 11 SEC Form 4 filings on record going back to 2024, most recently on 14 July 2026. Most recent open-market trade: sold $1.82M of CGON on 14 July 2026. Lifetime open-market sales: $6.28M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by James Mulay.
InsiderAlpha's records for James Mulay go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. 27 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
